International Journal of Clinical Pediatrics, ISSN 1927-1255 print, 1927-1263 online, Open Access
Article copyright, the authors; Journal compilation copyright, Int J Clin Pediatr and Elmer Press Inc
Journal website http://www.theijcp.org

Case Report

Volume 8, Number 1, August 2019, pages 8-11


Rapid Response to Low-Dose Rituximab Following Development of Severe Hemophagocytic Lymphohistiocytosis Due to Epstein-Barr Virus Infection

Figures

Figure 1.
Figure 1. Microscopic findings of bone marrow specimens on day 1. Bone marrow showed monocytic infiltration with a background of hypocellular lesion (May-Giemsa stain, × 400). Lymphocytes account for 12% of total nucleated cells, comprising the following subsets: CD3, 93%; CD4, 36%; CD8, 55%; CD19, 2%; CD56, 4%.
Figure 2.
Figure 2. Response to prednisolone, cyclosporine and rituximab. The patient did not respond to first-line therapy with prednisolone. A high level of EBV-DNA was identified on day 4. After the first course of rituximab that was administered on day 5, disease activity rapidly declined. CsA: cyclosporine; DIC: disseminated intravascular coagulation; EBV: Epstein-Barr virus; Plt: platelets; PSL: prednisolone; WBC: white blood cells.

Table

Table 1. Laboratory Data
 
Normal rangeOn admissionOutpatient clinic
day 1day 2day 4day 5day 6day 7day 8day 9day 11day 13day 15day 18day 30day 56day 126day 195
Alb: albumin; ALT: alanine aminotransferase; ANA: anti-nuclear antibody; AST: aspartate aminotransferase; AT: antithrombin; Cr: creatinine; CRP: C-reactive protein; FDP: fibrin and fibrinogen degradation product; Hb: hemoglobin; LDH: lactate dehydrogenase; PIC: plasmin-α2-plasmin inhibitor complex; Plt: platelets; PT: prothrombin time ; sIL2R: soluble interleukin 2 receptor; TAT: thrombin-antithrombin complex; TB: total bilirubin; TP: total protein; UN: urea nitrogen; WBC: white blood cells; Nd: not determined.
WBC (109/L)3.3 - 8.6110.31.41.92.43.68.45.94.53.13.43.62.94.43.8
  Neutrophil (%)6495949696.5Nd95937268726874717669
  Lymphocyte (%)284333Nd221813161320232026
  Monocyte (%)71310.5Nd45101912165444
Hb (g/L)116 - 14813712610710411310297989599111113124127135132
Reticulocyte (‰)4 - 20795332233451035116101014
Plt (109/L)158 - 3484858363348334777139235310346178171198195
TB (mg/L)3 - 129.67.4610.8138.96.67.77.58.79.110.59.95.76.36.3
AST (U/L)13 - 3092143227272247218125847345402424222329
ALT (U/L)10 - 4270631021541711651261071321061055521153438
LDH (U/L)124 - 2226928251,0461,2971,245901677497420385317238175130156144
UN (mg/L)80 - 190747985831031051481341281332101998612210684
Cr (mg/L)5 - 98.18.26.14.75.25.255.14.64.75.65.35.85.66.46
TP (g/L)65 - 8063514543464751585967716973677167
Alb (g/L)38 - 5336292423262730393944484851474946
Ferritin (µg/L)20 - 1201,921NdNdNd8,479.9Nd3,849.6Nd1,842Nd307.8Nd5896.911
sIL2-R (U/mL)145 - 5199,090NdNdNd14,400NdNdNd4,880Nd1,680Nd434182261248
CRP (mg/L)0 - 280.366.140.131.818.910.36.94.42.51.2< 1< 1< 1< 1< 1< 1
ANA(-)Negative
PT ratio0.9 - 1.11.261.131.181.090.990.940.90.860.90.90.910.9311.02NdNd
Fibrinogen (g/L)1.5 - 4.03.342.771.531.441.221.271.131.261.211.231.461.52862.23NdNd
FDP (mg/L)< 513.920.8104.667.855.330.51811.17.1< 5< 5< 5< 5< 5NdNd
D-dimer (mg/L)< 1132088.548.34528.115.995.52.71.8< 1< 1< 1NdNd
AT (%)70 - 13097878289109120128135144144> 150> 150140132NdNd
TAT (µg/L)< 326.85980.25238.321.412.42.92.72.91.51.5< 1NdNdNd
PIC (mg/L)< 12.73.1Nd5.86.46.34.2321.41.5< 1< 1NdNdNd
Urinalysis
  Protein(-)+/-1+1+1+1++/-+/--Nd---NdNdNdNd
  Blood(-)+/-3+2+1+----Nd---NdNdNdNd
  Sugar(-)--------Nd---NdNdNdNd
Blood cultureNegative